Literature DB >> 33539332

Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program - United States, December 2020-January 2021.

Radhika Gharpure, Angela Guo, Courtney Krier Bishnoi, Urvi Patel, David Gifford, Ashley Tippins, Aaron Jaffe, Evan Shulman, Nimalie Stone, Elisabeth Mungai, Suparna Bagchi, Jeneita Bell, Arjun Srinivasan, Anita Patel, Ruth Link-Gelles.   

Abstract

Residents and staff members of long-term care facilities (LTCFs), because they live and work in congregate settings, are at increased risk for infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) (1,2). In particular, skilled nursing facilities (SNFs), LTCFs that provide skilled nursing care and rehabilitation services for persons with complex medical needs, have been documented settings of COVID-19 outbreaks (3). In addition, residents of LTCFs might be at increased risk for severe outcomes because of their advanced age or the presence of underlying chronic medical conditions (4). As a result, the Advisory Committee on Immunization Practices has recommended that residents and staff members of LTCFs be offered vaccination in the initial COVID-19 vaccine allocation phase (Phase 1a) in the United States (5). In December 2020, CDC launched the Pharmacy Partnership for Long-Term Care Program* to facilitate on-site vaccination of residents and staff members at enrolled LTCFs. To evaluate early receipt of vaccine during the first month of the program, the number of eligible residents and staff members in enrolled SNFs was estimated using resident census data from the National Healthcare Safety Network (NHSN†) and staffing data from the Centers for Medicare & Medicaid Services (CMS) Payroll-Based Journal.§ Among 11,460 SNFs with at least one vaccination clinic during the first month of the program (December 18, 2020-January 17, 2021), an estimated median of 77.8% of residents (interquartile range [IQR] = 61.3%- 93.1%) and a median of 37.5% (IQR = 23.2%- 56.8%) of staff members per facility received ≥1 dose of COVID-19 vaccine through the Pharmacy Partnership for Long-Term Care Program. The program achieved moderately high coverage among residents; however, continued development and implementation of focused communication and outreach strategies are needed to improve vaccination coverage among staff members in SNFs and other long-term care settings.

Entities:  

Year:  2021        PMID: 33539332     DOI: 10.15585/mmwr.mm7005e2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  33 in total

1.  Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020-July 2021.

Authors:  Andrew I Geller; Daniel S Budnitz; Heather Dubendris; Radhika Gharpure; Minn Soe; Hsiu Wu; Elizabeth J Kalayil; Andrea L Benin; Suchita A Patel; Megan C Lindley; Ruth Link-Gelles
Journal:  Public Health Rep       Date:  2022-02-05       Impact factor: 2.792

2.  COVID-19 vaccination coverage among healthcare workers in obstetrics and gynecology during the first three months of vaccination campaign: a cross-sectional study in Jiangsu province, China.

Authors:  Yaning Zheng; Ping Shen; Biyun Xu; Yiying Chen; Yuqian Luo; Yimin Dai; Yali Hu; Yi-Hua Zhou
Journal:  Hum Vaccin Immunother       Date:  2021-11-22       Impact factor: 3.452

3.  First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.

Authors:  Radhika Gharpure; Anita Patel; Ruth Link-Gelles
Journal:  JAMA       Date:  2021-04-27       Impact factor: 56.272

4.  COVID-19 Vaccine Acceptability Among Clients and Staff of Homeless Shelters in Detroit, Michigan, February 2021.

Authors:  Ashley A Meehan; Michael Yeh; Annette Gardner; Tiera L DeFoe; Alberto Garcia; Patrick Vander Kelen; Martha P Montgomery; Ashley E Tippins; Andrea E Carmichael; Rachael Gibbs Chw; Hayat Caidi; Emily Mosites; Najibah Rehman
Journal:  Health Promot Pract       Date:  2021-10-23

5.  The BNT162b2 vaccine is associated with lower new COVID-19 cases in nursing home residents and staff.

Authors:  Marsida Domi; Michael Leitson; David Gifford; Anna Nicolaou; Kiran Sreenivas; Courtney Bishnoi
Journal:  J Am Geriatr Soc       Date:  2021-05-18       Impact factor: 7.538

6.  Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021.

Authors:  Amadea Britton; Kara M Jacobs Slifka; Chris Edens; Srinivas Acharya Nanduri; Stephen M Bart; Nong Shang; Adora Harizaj; Jillian Armstrong; Kerui Xu; Hanna Y Ehrlich; Elizabeth Soda; Gordana Derado; Jennifer R Verani; Stephanie J Schrag; John A Jernigan; Vivian H Leung; Sunil Parikh
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-03-19       Impact factor: 17.586

7.  Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members - Chicago, Illinois, December 2020-March 2021.

Authors:  Richard A Teran; Kelly A Walblay; Elizabeth L Shane; Shannon Xydis; Stephanie Gretsch; Alexandra Gagner; Usha Samala; Hyeree Choi; Christy Zelinski; Stephanie R Black
Journal:  Am J Transplant       Date:  2021-06       Impact factor: 8.086

8.  Attitudes towards COVID-19 Vaccination among Hospital Staff-Understanding What Matters to Hesitant People.

Authors:  Anne Spinewine; Catherine Pétein; Perrine Evrard; Christelle Vastrade; Christine Laurent; Bénédicte Delaere; Séverine Henrard
Journal:  Vaccines (Basel)       Date:  2021-05-06

9.  Maximization of Open Hospital Capacity under Shortage of SARS-CoV-2 Vaccines-An Open Access, Stochastic Simulation Tool.

Authors:  Wolfram A Bosbach; Martin Heinrich; Rainer Kolisch; Christian Heiss
Journal:  Vaccines (Basel)       Date:  2021-05-22

10.  Mathematical Modeling to Inform Vaccination Strategies and Testing Approaches for Coronavirus Disease 2019 (COVID-19) in Nursing Homes.

Authors:  Rebecca Kahn; Inga Holmdahl; Sujan Reddy; John Jernigan; Michael J Mina; Rachel B Slayton
Journal:  Clin Infect Dis       Date:  2022-03-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.